Biomerica Revenue, Profits - BMRA Annual Income Statement

Add to My Stocks
$3.35 $0.02 (0.59%) BMRA stock closing price Sep 20, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Biomerica stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the BMRA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue growth of 12.87% when compared to the same period in the past. Revenue for year 2017 is $5.79M and has increased from $5.13M year on year as is evident when you compare the latest figures in the latest Biomerica profit and loss statement with those of the prior corresponding period. Also see Biomerica assets and Biomerica free cash flow for a complete valuation of BMRA stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jun - May201720162015201420132012201120102009
Biomerica Revenues or Net Sales
5.79M5.13M4.96M5.12M6.47M6.08M4.89M5.07M4.93M
Cost Of Goods Sold (COGS)3.76M3.61M3.42M3.45M4.04M3.78M3.37M3.51M2.96M
Biomerica Gross Profit
2.02M1.52M1.54M1.66M2.42M2.29M1.52M1.56M1.96M
Research & Development Expense1.13M--------
Selling General & Admin Expense1.84M1.57M1.47M1.52M1.45M1.44M1.23M1.47M1.44M
Income Before Depreciation Depletion Amortization-0.95M-0.82M-0.67M-0.44M---0.13M-0.36M-
Depreciation Depletion Amortization---------
Non Operating Income---------
Interest Expense---------
Biomerica Pretax Income
-0.9M-0.79M-0.64M-0.42M----0.34M-
Provision for Income Taxes---0.31M-0.21M-0.01M---0.01M-0.08M
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-0.9M-1.49M-0.33M-0.21M----0.33M-
Extraordinary Items & Discontinued Operations---------
Biomerica Profit/ Loss (Net Income)
-0.9M-1.49M-0.33M-0.21M----0.33M-
Average Shares used to compute Diluted EPS8.33M7.63M7.55M7.37M7.45M7.11M6.7M6.65M7.01M
Average Shares used to compute Basic EPS8.33M7.63M7.55M7.37M7.02M6.89M6.67M6.65M6.62M
Income Before Nonrecurring Items-0.91M-1.5M-0.33M-0.22M----0.18M-
Income from Nonrecurring Items--------0.15M-
Biomerica Earnings Per Share Basic Net
-0.11-0.20-0.04-0.030.080.080.02-0.050.05
Biomerica Earnings Per Share Diluted Net
-0.11-0.20-0.04-0.030.070.080.02-0.050.05
EPS Diluted Before Nonrecurring Items-0.11-0.20-0.04-0.030.070.080.02-0.030.05
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Biomerica stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $5.79M for this year of 2017. Our Biomerica revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-0.9M for BMRA stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the BMRA income statement, one can check the Biomerica historical stock prices to check how the price has moved with time.

Biomerica Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
5.02
Dividend Yield
0%